Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lapucci

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 17, 2026
Brain Microstructural Damage as Potential Biomarker of Immune Cell-Associated Neurotoxicity SyndromeCaterina Lapucci, Massimiliano Gambella, Emilio Cipriano, et al.
Brain, Behavior, and Immunity|July 2, 2015
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS reboundLeonardo Cavone, Roberta Felici, Andrea Lapucci, et al.
Molecular Pharmacology|November 9, 2007
Impact of targeting the adenine- and uracil-rich element of bcl-2 mRNA with oligoribonucleotides on apoptosis, cell cycle, and neuronal differentiation in SHSY-5Y cellsLaura Papucci, Ewa Witort, Anna Maria Bevilacqua, et al.
European Journal of Neurology|April 18, 2026
Assessing Optic Nerve Involvement in Multiple Sclerosis Using Optical Coherence Tomography and Magnetic Resonance ImagingGualco Alessandro, Boffa Giacomo, Razzetta Chiara, et al.
Drugs - Real World Outcomes|June 1, 2026
Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter CohortVincenzo Mangialardi, Giuseppe Macchitella, Rita Vitobello, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 28, 2010
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemiaAndrea Lapucci, Matteo Lulli, Amedeo Amedei, et al.
Cell and Tissue Research|March 12, 2004
Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expressionLaura Papucci, Lucia Formigli, Nicola Schiavone, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Different MRI patterns in MS worsening after stopping fingolimodCaterina Lapucci, Damiano Baroncini, Maria Cellerino, et al.
European Journal of Neurology|August 18, 2020
Assessing upper limb function in multiple sclerosis using an engineered gloveL Carmisciano, A Signori, M Pardini, et al.
European Journal of Neurology|May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumabG Boffa, C Lapucci, E Sbragia, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 17, 2026
Brain Microstructural Damage as Potential Biomarker of Immune Cell-Associated Neurotoxicity SyndromeCaterina Lapucci, Massimiliano Gambella, Emilio Cipriano, et al.
Brain, Behavior, and Immunity|July 2, 2015
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS reboundLeonardo Cavone, Roberta Felici, Andrea Lapucci, et al.
Molecular Pharmacology|November 9, 2007
Impact of targeting the adenine- and uracil-rich element of bcl-2 mRNA with oligoribonucleotides on apoptosis, cell cycle, and neuronal differentiation in SHSY-5Y cellsLaura Papucci, Ewa Witort, Anna Maria Bevilacqua, et al.
European Journal of Neurology|April 18, 2026
Assessing Optic Nerve Involvement in Multiple Sclerosis Using Optical Coherence Tomography and Magnetic Resonance ImagingGualco Alessandro, Boffa Giacomo, Razzetta Chiara, et al.
Drugs - Real World Outcomes|June 1, 2026
Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter CohortVincenzo Mangialardi, Giuseppe Macchitella, Rita Vitobello, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 28, 2010
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemiaAndrea Lapucci, Matteo Lulli, Amedeo Amedei, et al.
Cell and Tissue Research|March 12, 2004
Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expressionLaura Papucci, Lucia Formigli, Nicola Schiavone, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Different MRI patterns in MS worsening after stopping fingolimodCaterina Lapucci, Damiano Baroncini, Maria Cellerino, et al.
European Journal of Neurology|August 18, 2020
Assessing upper limb function in multiple sclerosis using an engineered gloveL Carmisciano, A Signori, M Pardini, et al.
European Journal of Neurology|May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumabG Boffa, C Lapucci, E Sbragia, et al.
Pageof 24